Novel Vaccines for Pediatric Falciparum Malaria

Provided by: PENN-CHOP Blood Center for Patient Care and Discovery 2016-2017

Novel Vaccines for Pediatric falciparum Malaria April 12, 2017 12:00-1:00pm BRB II/III, 14th Floor, Faculty Lounge Jonathan Kurtis, MD, PhD Director, Center for International Health Research, Rhode Island Hospital Professor, Department of Pathology and Laboratory Medicine, Brown University School of Medicine Associate Director, Transfusion Medicine and Coagulation

Target Audience This program has been designed for physicians, fellows, residents, medical students, researchers and lab members in hematology.

Series Educational Objectives After completing this activity, participants should be able to:  Appropriately diagnose and treat patients with thalassemia  Appropriately diagnose and manage patients with transfusion needs  Improve recognition and management of the bone marrow failure disorders Session Educational Objectives After completing this activity, participants should be able to:  Discuss the transmission, pathogenesis and public health impact of falciparum malaria  Explain the rational vaccine design approaches for infectious diseases Accreditation Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council For Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.

Acknowledgement of Commercial Support* NONE

For more information, please contact Terese Manganaro 215-573-3288 [email protected] Check your CME online at www.penncmeonline.com Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Development for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME, Zalman Agus, MD, Senior peer reviewer and Patricia A. Smith, DNP, RN-BC, Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

PLANNING COMMITTEE MEMBER NAME CHARLES ABRAMS, MD MORTIMER PONCZ, MD DONALD SIEGEL, MD, PHD WEI TONG, PHD PRESENTER NAME JONATHAN KURTIS, MD, PHD

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity. PLANNING COMMITTEE MEMBER NAME NAME OF COMMERCIAL INTEREST RELATIONSHIP Adam Cuker, MD, MS Biogen-Idec, Spark Therapeutics, T2 Biosystems Investigator Biogen-Idec, Stago Speaker Rivella Stefano, PhD Novartis Pharma Consultant Ionis Pharma, Meira GTX Scientific Advisory Board Merganser Biotech Sponsored Research Agreement PRESENTER NAME NAME OF COMMERCIAL INTEREST RELATIONSHIP

Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

DISCLOSURE OF UNAPPROVED USES OF PRODUCTS

PRESENTER NAME PRODUCT INVESTIGATIONAL AND/OR OFF-LABEL USE